Récepteurs des facteurs de croissance fibroblastique (FGFR) et anomalies héréditaires de l'ossification enchondrale et membranaire

Medecine/Sciences

Volumn 12, Issue SPEC. ISS., 1996, Pages 44-49

  Bonaventure, Jacky ^a   Rousseau, Francis ^a   Legeai Mallet, Laurence ^a   Benoist, Catherine ^a   Le Merrer, Martine ^a   Munnich, Arnold ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0010752064     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Blanquet PR. Les signaux des FGF: un mécanisme qui commence à être déchiffré. médecine/sciences 1996; 12: 303-12.
2. Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990; 61: 203-12.
3. Mason IJ. The ins and outs of fibroblast growth factors. Cell 1994; 78: 547-52.
4. Basilico C, Moscatelli D. The FGF family of growth factors and oncogenes. Adv Cancer Res 1992; 59: 115-65.
5. Peters K, Ornitz DM, Werner S, Williams LT. Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis. Dev Biol 1993; 155: 423-30.
6. Le Merrer M, Rousseau F, Legeai-Mallet L, Landais JC, Pelet A, Bonaventure I, Sanak M, Weissenbach J, Stoll C, Munnich A, Maroteaux P. A gene for achondroplasia-hypochondroplasia maps to chromosome 4p. Nature Genet 1994; 6: 318-21.
7. Rousseau F, Bonaventure J, Legeai-Mallet L, Pelet A, Rozet JM, Maroteaux P, Le Merrer M, Munnich A. Mutations in the gene encoding fibroblast growth factor receptor 3 in achondroplasia. Nature 1994; 371: 252-4.
8. Shiang R, Thompson LM, Zhu YZ, Church DM, Fielder TJ, Bocian M, Winokur ST, Wasmuth JJ. Mutations in the transmembrane domain of FGFR 3 cause the most common genetic form of dwarfism, achondroplasia. Cell 1994; 78: 336-42.
9. Tavormina PL, Shiang R, Thompson LM, Zhu YZ, Wilkin DJ, Lachman RS, Wilcox WR, Rimoin DL, Cohn DH, Wasmuth JJ. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nature Genet 1995; 9: 321-8.
10. Rousseau F, Saugier P, Le Merrer M, Munnich A, Delezoide AL, Maroteaux P, Bonaventure J, Narcy F, Sanak M. Stop codon FGFR 3 mutations in thanatophoric dwarfism type I. Nature Genet 1995; 10: 11-2.
11. Rousseau F, El Ghouzzi V, Delezoide AL, Legeai-Mallet L, Le Merrer M, Munnich A, Bonaventure J. Missense FGFR 3 mutations create cysteine residues in thanatophoric dwarfism type I (TD I). Hum Mol Genet 1996; 5: 509-12.
12. Reardon W, Winter RM, Rutland P, Pulleyn L, Jones BM, Malcolm S. Mutations in the fibroblast growth factor receptor 2 cause Crouzon syndrome. Nature Genet 1994; 8: 98-103.
13. Muenke M, Schell U, Hehr A, Robin NH, Losken W, Schinzel A, Pulleyn LJ, Rutland P, Reardon W, Malcolm S, Winter RM. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nature Genet 1994; 8: 269-74.
14. Lajeunie E, Ma HW, Bonaventure J, Munnich A, Le Merrer M, Rénier D. FGFR 2 mutations in Pfeiffer syndrome. Nature Genet 1995; 9: 108.
15. Meyers GA, Orlow SJ, Munro IR, Przylepa KA, Jabs EW. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nature Genet 1995; 11: 462-4.
16. Spivak-Kroizman T, Lemmon MA, Dikic I, Ladbury JE, Pinchasi D, Huang J, Jaye M, Crumley G, Schlessinger J, Lax I. Heparin-inducea oligomerizauon of FGF molecules is responsible for FGF receptor dimerization, activation and cell proliferation. Cell 1994; 79: 1015-24.
17. Reimold AM, Grusby MJ, Kosaras B, Fries JWU, Mori R, Maniwa S, Clauss IM, Collins T, Sidman RL, Glimcher MJ, Glimcher LH. Chondrodysplasia and neurological abnormalities in ATF-2 deficient mice. Nature 1996; 379: 262-5.
18. Webster MK, Donoghue DJ. Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. EMBO J 1996; 15: 520-7.
19. Nielson KM, Friesel RE. Constitutive activation of fibroblast growth factor receptor 2 by a point mutation associated with Crouzon syndrome. J Biol Chem 1995; 270: 26037-40.
20. Deng C, Wynshaw-Boris A, Zhou F, Kuo A, Leder P. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 1996; 84: 911-21.